Hyperion DeFi, Inc. Common Stock (HYPD)

• Market cap: $39.7M
• 1 day: 14.43%
• 5 days: 2.65%
• 1 month: -26.53%
• 3 months: 350.32%
• 6 months: 296.59%
• Year to date: -27.29%
• 1 year: -83.55%
• 5 years: -97.60%
• 10 years: -99.12%
• Sector: Healthcare
• Industry: Biotechnology

About: Hyperion DeFi Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or New combinations.

Employees: 57

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

376% more capital invested

Capital invested by funds: $306K [Q1] → $1.46M (+$1.15M) [Q2]

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

6% more funds holding

Funds holding: 18 [Q1] → 19 (+1) [Q2]

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

7.57% less ownership

Funds ownership: 13.26% [Q1] → 5.69% (-7.57%) [Q2]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q1] → 0 (-1) [Q2]

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $57K